Medicenna Therapeutics (MDNAF) Q4 2024 Earnings

15NovConfirmed
May 20
Aug 20
Q3 2024
Q4 2024
-0.07
-0.06
-0.05
-0.03

Details

Expected EPS
-0.04803825
Actual EPS
-0.0369525
Surprise EPS
0.01
Surprise Percent
+23.08%

Description

Medicenna Therapeutics (MDNAF) has reported earnings of -0.0369525 per share for Q4 2024.

0 Comments

Share your thoughts